VF
MYGN icon

Virtu Financial’s Myriad Genetics MYGN Stock Holding History

Virtu Financial’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-93,668
Closed -$422K – 2012
2026
Q1 		$422K Buy
+93,668
New +$488K 0.02% 639
2024
Q1 		– Sell
-22,366
Closed -$428K – 1845
2023
Q4 		$428K Buy
+22,366
New +$387K 0.03% 458
2019
Q4 		$223K Buy
+8,176
New +$225K 0.02% 864
2019
Q2 		– Sell
-7,061
Closed -$234K – 1711
2019
Q1 		$234K Buy
+7,061
New +$215K 0.01% 920
2015
Q3 		– Sell
-8,818
Closed -$300K – 374
2015
Q2 		$300K Buy
+8,818
New +$300K 0.03% 260

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial's MYGN Position: Q2 2026 in Review

Virtu Financial sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 93,668 shares — an estimated $422K sold.

Virtu Financial first reported a position in MYGN in Q2 2015 and held it in 5 quarters. The position peaked at $428K in Q4 2023. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Virtu Financial reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 93,668 Myriad Genetics shares in Q2 2026, an estimated $422K.
  • Virtu Financial first reported a position in Myriad Genetics in Q2 2015 and held it in 5 quarters.
  • Virtu Financial's Myriad Genetics position peaked at $428K in Q4 2023.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.